scholarly journals Polycystic ovary syndrome and cardiovascular risk. Could trimethylamine N-oxide (TMAO) be a major player? A potential upgrade forward in the DOGMA theory

2021 ◽  
Vol 143 ◽  
pp. 112171
Author(s):  
Giuseppe Annunziata ◽  
Roberto Ciampaglia ◽  
Xavier Capò ◽  
Fabrizia Guerra ◽  
Antoni Sureda ◽  
...  
2008 ◽  
Vol 4 (6) ◽  
pp. 583-594 ◽  
Author(s):  
Charikleia D Christakou ◽  
Evanthia Diamanti-Kandarakis

Polycystic ovary syndrome (PCOS) is associated with a clustering of metabolic and cardiovascular risk factors. Insulin resistance is implicated as the major player in the metabolic abnormalities and contributes to the increased cardiovascular risk associated with the syndrome. However, androgen excess appears to participate as an independent parameter, which further aggravates the cardiovascular and metabolic aberrations in affected women with PCOS. The resultant impact of hyperandrogenemia possibly acquires clinical significance for women's health in the context of PCOS, particularly since recent data support an increased incidence of coronary artery disease and of cardiovascular events directly related to androgen levels in women with the syndrome.


2005 ◽  
Vol 113 (S 1) ◽  
Author(s):  
S Tan ◽  
S Hahn ◽  
K Pleger ◽  
S Sack ◽  
BL Herrmann ◽  
...  

2009 ◽  
pp. 1-7
Author(s):  
Tanzeela Akram ◽  
Shahid Hasan ◽  
Muhammad Imran ◽  
Asima Karim ◽  
Muhammad Arslan

2010 ◽  
Vol 34 (6) ◽  
pp. 422-426 ◽  
Author(s):  
M. Rizzo ◽  
R. A. Longo ◽  
E. Guastella ◽  
G. B. Rini ◽  
E. Carmina

2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Hassan Kahal ◽  
Stephen L. Atkin ◽  
Thozhukat Sathyapalan

Polycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age and it is associated with increased cardiovascular risk. Obesity plays an important role in the pathogenesis of PCOS, and the majority of patients with PCOS are obese. Over the last 20 years, the prevalence of obesity has dramatically increased, with probable associated increase in PCOS. Weight reduction plays an integral part in the management of women with PCOS. In this paper, current available weight reduction therapies in the management of PCOS are discussed.


2016 ◽  
Vol 2016 ◽  
pp. 1-11 ◽  
Author(s):  
Tommy Kyaw Tun ◽  
Anne McGowan ◽  
Niamh Phelan ◽  
Neuman Correia ◽  
Gerard Boran ◽  
...  

Postprandial dyslipidaemia may be a plausible mechanism by which polycystic ovary syndrome (PCOS) increases cardiovascular risk. We sought to investigate whether the postprandial glucose and insulin and lipid and lipoprotein responses, including that of apolipoprotein B-48 (apoB-48) containing chylomicrons, to a mixed meal are different in obese PCOS women when compared to obese control subjects and whether differences, if any, are related to obesity, insulin resistance (IR), hyperandrogenaemia, or PCOS status. 26 women with PCOS (age30.4±1.2years (mean ± SEM), body mass index (BMI)36.8±1.5 kg/m2) and 26 non-PCOS subjects (age34.1±0.9years, BMI31.5±1.0 kg/m2) were studied before and up to 8 hours following a standard mixed meal. AUC-triglyceride (AUC-TG) was higher and AUC-high-density lipoprotein (AUC-HDL) lower in PCOS women. These differences were not apparent when BMI was accounted for. Insulin sensitivity (SI), AUC-apoB-48, and AUC-apolipoprotein B (AUC-apoB) were found to be independent predictors of AUC-TG, accounting for 55% of the variance. Only AUC-insulin remained significantly elevated following adjustment for BMI. Obesity related IR explains postprandial hypertriglyceridaemia and hyperinsulinaemic responses. Management of obesity in premenopausal women with PCOS is likely to reduce their cardiovascular risk burden.


2008 ◽  
Vol 9 (10) ◽  
pp. 987-992 ◽  
Author(s):  
Francesco Giallauria ◽  
Francesco Orio ◽  
Stefano Palomba ◽  
Gaetano Lombardi ◽  
Annamaria Colao ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document